Soluble Guanylyl Cyclase α1 and p53 Cytoplasmic Sequestration and Down-Regulation in Prostate Cancer
Soluble Guanylyl Cyclase α1 and p53 Cytoplasmic Sequestration and Down-Regulation in Prostate Cancer
复制标题
DOI:
10.1210/me.2010-0394
复制
发表时间:
2012-02-01
影响因子:
--
通讯作者:
Shemshedini, Lirim
中科院分区:
文献类型:
--
作者:
Cai, Changmeng;Hsieh, Chen-Lin;Shemshedini, Lirim
Our laboratory has previously identified soluble guanylyl cyclase alpha 1 (sGC alpha 1) as a novel androgen-regulated gene essential for prostate cancer cell proliferation. sGC alpha 1 expression is highly elevated in prostate tumors, contrasting with the low expression of sGC alpha 1, with which sGC alpha 1 dimerizes to mediate nitric oxide (NO) signaling. In studying its mechanism of action, we have discovered that sGC alpha 1 can inhibit the transcriptional activity of p53 in prostate cancer cells independent of either classical mediators of NO signaling or the guanylyl cyclase activity of sGC alpha 1. Interestingly, sGC alpha 1 inhibition of p53-regulated gene expression was gene specific, targeting genes involved in apoptosis/cell survival. Consistent with this, overexpression of sGC alpha 1 makes prostate cancer cells more resistant to etoposide, a chemotherapeutic and apoptosis-inducing drug. Immunoprecipitation and immunocytochemistry assays show a physical and direct interaction between sGC alpha 1 and p53 in prostate cancer cells. Interestingly, sGC alpha 1 induces p53 cytoplasmic sequestration, representing a new mechanism of p53 inactivation in prostate cancer. Analysis of prostate tumors has shown a direct expression correlation between sGC alpha 1 and p53. Collectively, these data suggest that sGC alpha 1 regulation of p53 activity is important in prostate cancer biology and may represent an important mechanism of p53 down-regulation in those prostate cancers that express significant levels of p53. (Molecular Endocrinology 26: 292-307, 2012)